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Abstract 
Incubation of HER14 cells with phorbol myristate acetate (PMA) decreases epidermal growth factor (EGFf-dependent protein tyrosine phospho- 
rylation, except for a 40-kDa MAP kinase II-like protein, whose tyrosine phospho~lation is further enhanced. The inhibitor effect of PMA on 
EGF-dependent protein tyrosine phosphorylation is reversed if cells are pre-incubated with a combination of Na,VO, and NaF, two known inhibitors 
of protein tyrosine phosphatase activity. Protein tyrosine phosphatase activity of cell homogenate was measured on immunopurified EGF receptor, 
and was found to be enhanced in PMA-treated cells. These data suggest that the inhibitory effect of PMA on EGF-dependent protein tyrosine 
phosphorylation i  HER14 cells may be mediated by protein tyrosine phosphatase activity. 
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1. Introduction 
EGF-receptor (EGF-R)’ is a transmembrane protein 
tyrosine kinase, which upon ligand binding, undergoes 
an autophosphorylation on tyrosine residues and phos- 
phorylates other protein substrates [l]. Tumor promoter 
phorbol esters decrease high affinity binding of EGF, 
and inhibit the tyrosine kinase activity of EGF-R 12-51. 
This regulation is supposedly due to a protein kinase C 
(PKC)-mediated serine/threonine phosphorylation of 
EGF-R [WI. 
In addition, it was proposed that phosphorylation of 
EGF-R at Thr654 by PKC is necessary for inhibition of 
EGF-R kinase activity, as well as for negative control of 
EGF-induced mitogenesis and receptor intemalization 
[P-II]. Phosphorylation of EGF-R at threonine 669 
[12,13] might also regulate EGF-R signaling. Recently, 
Rosner and co-workers [14] suggested that pp42 MAP 
kinase decreases tyrosine phosphorylation of EGF-R by 
activating a vanadate-sensitive protein tyrosine phos- 
phatase. Although several studies have implicated pro- 
tein tyrosine phosphatases [15] in the regulation of pep- 
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tide growth factor-mediated protein tyrosine phospho- 
rylation [l&-19], the role of these enzymes in the PKC- 
mediated inhibition of EGF-R signaling was never inves- 
tigated. In this study, we show that protein tyrosine 
phosphatase activity in HER14 cells may mediate the 
inhibitory effect of PMA on EGF-dependent protein ty- 
rosine phosphorylation. 
2. Experimental 
NIH-3T3 cells transfected with the human EGF receptor (HER14 
cells) and the human epidermoid carcinoma cell line A431 (kindly 
provided by Dr. J. Schlessinger) were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% heat-inactivated 
fetal calf serum for A431 cells, or 10% calf serum for HER14 cells, 2 
mM glutamine and streptomycin (50 m~ml)/~ni~illin (50 W/ml), at 
5% CO2 in air and 37°C. Before starting the experiment, cells (50% to 
90% confluence) were starved 4 h in fresh media supplemented with 20 
mM HEPES (pH 7.4), and 0.5% serum. After cell treatment with PMA 
(Sigma) or with EGF (Toyobo Co), cell media was aspirated, followed 
by scraping of cells off the plates in buffer A (20 mM HEPES,lSO mM 
NaCl, 1 mM EGTA, 1.5 mM MgCl,, 10% glycerol, 1% Triton X-100, 
1 mM phenylmethylsulfonyl fluoride (PMSF), 1 yg/ml aprotinin and 
1 fig/ml leupeptin, pH 7.4.) with or without Na,V04 (1OOpM) and NaF 
(20 mM). Lysate was left at ice cold temperature for 30 mm, then was 
clarified by ~ntrifugation for 3 mm at 16,000 xg in a micr~nt~fuge. 
In the resulting supernatant (cell homogenate) proteins were measured 
by the Bio-Rad method [20] and matched, before being subjected to 
SDS-PAGE, followed by immunoblotting with anti-phosphotyrosine 
antibody as described [21]. 
“P-labeled EGF-R for the protein tyrosine phosphatase activity 
assay was prepared as follows: Cell homogenate was prepared from 
confluent A431 cells as described for HER14 cells, and was incubated 
for 90 min at 4°C under agitation with EGF-R monocional antibody, 
0014-5793/94/$7.~ 0 1994 Federation of European Biochemical Societies. All rights reserved, 
SSDI 0014-5793(94~0008-J 
8 M Errasfa. A SternlFEBS Letters 339 (19941 7-10 
mAblO8 [22] (kindly provided by Dr. J. Schlessinger) that was coupled 
to Protein A-Sepharose. The immunoprecipitate was washed twice with 
buffer B (20 mM HEPES. 350 mM NaCl. 10% Glvcerol. 0.1% Triton 
X-100, pH 7.4) and twice’with buffer B’ (Buffer B’with only 150 mM 
NaCl). The immunoprecipitate was then resuspended in 250 ,~l of 20 
mM HEPES (pH 7.4) in the presence of MgCl, (10 mM), S-10 ,&i 
[3ZP]ATP (6,000 Ci/mmol, from NEN), and cold ATP (100 PM). Phos- 
phorylation was carried out at room temperature and was terminated 
30 min later by centrifugation. The beads were washed three times with 
buffer B’, then were resuspended in 300400 ,~l of 20 mM HEPES (pH 
7.4) before utilization. Protein tyrosine phosphatase activity was meas- 
ured by incubating 40 ,~l of HER14 cell homogenate (54 pg) with 20 
,~l of “P-labeled EGF-R as a substrate. 20 min later, reaction was 
terminated by adding 60 ~1 of 2 x Laemmli sample buffer. Samples 
were boiled four min, and centrifuged in a microcentrifuge. An aliquot 
of the supernatant was subjected to SDS-PAGE (7.5%). The gel was 
dried in a Bio-Rad gel drier and than exposed to Kodak film for 0.5 
to 3 h at -70°C. Protein tyrosine phosphatase activity in each sample 
was estimated as a decrease of radioactivity associated with EGF recep- 
tor band compared to buffer A-treated substrate. The band corre- 
sponding to EGF-R was cut and counted in a beta counter by the 
Cerenkof method. The assay was performed in the linear range of 
32P-labeled EGF-R dephosphorylation with respect o time of incuba- 
tion and protein amount. 
Hieh affinitv binding assav of EGF was uerformed as described I1 11. 
Cells-were seeded in 2zwell plastic plates (j x lo4 cells/well). 48 h later, 
cells (20-25 x lO?well) were rinsed with binding buffer (DMEM sup- 
plemented with 20 mM HEPES and 1 mg/ml BSA) and incubated at 
37°C with the drugs to be studied. Cells were then transferred on ice, 
and 10 min later, “‘1-EGF (100 ,&i/pg, from ICN) (0.5 nM final) was 
added to the cells for an additional 3 h. Wells where non specific binding 
was to be determined were treated with cold EGF (50 nM final). Reac- 
tion was terminated by aspirating the media, and rinsing the cells three 
times with binding buffer. Then cells were solubilzed in 0.8 ml NaOH 
(0.5 N) at 37°C for one hour, then radioactivity was counted m an LKB 
gamma counter. 
3. Results 
Addition of 50 nM EGF to HER14 cells induced pro- 
tein tyrosine phosphorylation of several bands including 
that of the EGF-R (170 kDa). This effect was inhibited 
when cells were preincubated with 1 ,uM PMA, with the 
exception of a 40 kDa band whose tyrosine phosphoryl- 
ation was enhanced (Fig. 1, line 3). The 40 kDa band has 
been identified as a MAP kinase (Errasfa and Stern, 
personal communication). 
When cells were pre-treated with a combination of 
Na3V0, (0.1 mM) and NaF (20 mM), an enhancement 
of tyrosine phosphorylation was observed on several 
proteins (Fig. 1, line 4). After 50 nM EGF treatment in 
the presence of Na3V0, and NaF, protein tyrosine phos- 
phorylation also occurred on the EGF-R band (170 
kDa) and was increased on the 40 kDa band (Fig. 1, lines 
5). Na,VO, and NaF prevented the inhibitory effect of 
PMA on EGF-dependent protein tyrosine phosphoryla- 
tion, while tyrosine phosphorylation of the 40 kDa band 
was further enhanced (Fig. 1, line 6). When cells were 
pretreated with EGTA, the effect of PMA on EGF-de- 
pendent protein tyrosine phosphorylation was not signif- 
icantly modified (Fig. 1, line 9), indicating that Ca*’ may 
not be required. 
Since the inhibitory effect of PMA on EGF-dependent 
protein tyrosine phosphorylation was reversed by a com- 
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Fig. 1. Inhibition of m vivo EGF-dependent protein tyrosine phospho- 
rylation by PMA is reversed by Na,VO, and NaF, but not EGTA. 
Serum-starved HER14 cells were incubated 3040 min with a combina- 
tion (lines 46) of 100 ,uM Na,VO, and 20 mM NaF, or with 2.5 mM 
ethylene glycol bis-@-ammoethyl ether) N,N,N,K-tetraacetic acid 
(EGTA) (lines 7-9). Then dimethylsulfoxide (DMSO, 0.2%) (lines 
1,2,4,5,7,8) or 1 ,uM PMA (lines 3,6 and 9) was added for five min. 50 
nM EGF was added for an additional five mm (lines 2,3.5,6,8,9). Tyro- 
sme phosphorylated proteins were analysed as described in Section 2. 
bination of two protein tyrosine phosphatase inhibitors, 
we investigated the effect of PMA on protein tyrosine 
phosphatase activity in HER14 cells. Protein tyrosine 
phosphatase activity was measured in cell homogenate 
in the presence of 32P-labeled immunopurified EGF-R as 
a substrate in vitro (Fig. 2). Cell homogenate xhibited 
a PTPase activity toward 32P-labeled EGF-R. This activ- 
ity was found to be significantly enhanced in PMA- 
treated cells in a concentration- and time-dependent 
manner (Fig. 2,A,B). About 35% of EGF-R was 
dephosphorylated by cell homogenate derived from con- 
trol cells, while 59% of this substrate was 
dephosphorylated by cell homogenate of PMA-treated 
cells (Fig. 2, see inset on page 16 of this manuscript). 
PMA is known to decrease high-affinity binding of 
EGF [lo]. We confirmed this finding and also investi- 
gated the effect of Na,VO, and NaF on high-affinity 
binding of EGF. As shown in Table 1, PMA decreased 
high-affinity binding of “‘1-EGF to HER14 cells. The 
combination of NaF and Na,VO,, also decreased the 
high-affinity binding of ‘251-EGF, which did not change 
in the presence of PMA (Table 1). This result appears 
paradoxical because EGF-dependent protein tyrosine 
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phosphorylation is enhanced by treatment of cells with 
Na,VO, and NaF in the presence of PMA (Fig. 1). 
4. Discussion 
We have found that the major effect of PMA on regu- 
lation of EGF-dependent protein tyrosine phosphoryla- 
tion in HER14 cells was an inhibition of protein tyrosine 
phosphorylation, accompanied by the enhancement of 
tyrosine phospho~latio~ of a 40 kDa MAP kinase-re- 
lated protein. To investigate the role of protein tyrosine 
phosphatases in the EGF-dependent inhibition of pro- 
tein tyrosine phosphorylation by PMA, we used two 
inhibitors of these enzymes, Na,VO, and NaF. Elevation 
of the basal tyrosine phosphorylation of several proteins 
and the increase in EGF-dependent tyrosine phosphoryl- 
ation of the 40 kDa protein in the presence of the inhib- 
itors is consistent with inhibition of protein tyrosine 
phosphatases. Consequently, the reversal of the inhib- 
itory effect of PMA on EGF-dependent protein tyrosine 
phosphorylation in HER14 cells by the protein tyrosine 
phosphatase inhibitors suggests amediating role for pro- 
tein tyrosine phosphatase activity in this action of PMA. 
This is supported by the observation that protein tyro- 
sine phosphatase activity in cell homogenate was signifi- 
cantly enhanced in PMA-treated ceils. 
The involvement of protein tyrosine phosphatases in 
the PMA effect on EGF-dependent protein tyrosine 
phosphorylation is compatible with a study by Brautigan 
and Pinault [ 151 which showed a PMA-dependent stimu- 
lation of protein tyrosine phosphatase activity on an 
artificial substrate. A recent finding by Rosner and co- 
workers fl9] showed that pp42 MAP kinase enhances 
Table 1 
Effect of PMA, Na,VO, and NaF on high-affinity binding of EGF in 
HER14 cells 
HER14 cells Exp 1 Exp 2 Exp 3 
Control 
PMA 
Na,VO,/NaF 
Na,VO,/NaF/ 
PMA 
3,327 4,916 3,527 
629 1,229 739 
523 624 1,358 
518 619 858 
Cells were seeded in 24-well plastic plates (5 x lo4 cells/well). 48 h later, 
cells (20-25 x lO“/well) were rinsed with binding buffer (DMEM sup- 
plemented with 20 mM HEPES and 1 mglml BSA) and incubated for 
40 min at 37°C in the same buffer containing Na,VO, (100 FM) and 
NaF (20 mM). Then PMA (1 PM) or DMSO (0.2%) was added for an 
additional 15 min. Plates were transferred on ice and 10 min later, 
?-EGF (0.5 nM final) was added to the cells for an additional 3 h. 
Wells where non specific binding was to be determined were also treated 
with cold EGF (50 nM final). Reaction was terminated by aspirating 
the media, and rinsing the cells three times with binding buffer. Then 
cells were solubiliid in 0.8 ml NaOH (0.5 N) for one hour at 37”C, and 
radioactivity was counted in an LKB gamma counter. Data in cpm are 
from three representative experiments. nd, not determined. 
5 
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Fig. 2. Modulation of protein tyrosine phosphatase activity in HER14 
cells by PMA and EGF. Serum-starved HER 14 cells were incubated for 
fifteen min with increasing concentrations of PMA (A) (0.01, 0.1 and 
1 PM in lines 3,4 and 5, respectively), or with 1 PM PMA for increasing 
time periods (B) ( 1, 3, 15 and 30 min, lines 3 through 6, respectively). 
Control cells (line 2 in A and B) received DMSO (0.2%). Reaction was 
terminated and homogenate was prepared to measure protein tyrosine 
phosphatase activity on “P-labeled EGF-R as a substrate (see Section 
2). Line 1 (A,B) refers to radioactive EGF-R incubated with buffer A 
alone. The inset (see page 16 of this manuscript) shows data in cpm 
(mean It S.E.M. of five experiments) of radioactivity associated with 
“P-labeled EGF-R when incubated with buffer A alone, or with cell 
homogenate derived from cells that have been treated for 15 min with 
either DMSO or PMA. DMSO and PMA treatments are compared 
using two tail Student’s f-test. 
Buffer 
DMSO 
PMA 
P < 0.02. 
16,142 + 2,383 
10,445 + 2,507 
6,578 & 1,767 
EGF-R dephosphorylation through the stimulation of a 
vanadate-sensitive protein tyrosine phosphatase. This 
mode of regulation of EGF-R is similar to our present 
finding, in that the negative regulation of EGF-R signal- 
ing induced by a serinelthreonine MAP kinase is medi- 
ated by a protein tyrosine phosphatase [19]. As MAP 
kinase is known to be activated by peptide growth fac- 
tors and phorbol esters [23,24], the question remains as 
to whether or not MAP kinase mediates the PMA effect 
on protein tyrosine phosphatase activation. 
In conclusion, EGF-dependent protein tyrosine phos- 
phorylation in HER14 cells may be inhibited by PMA 
through a PKC-activated protein tyrosine phosphatase 
and the decrease of high-affinity binding of EGF caused 
by PMA may not be relevant to the inhibition of EGF- 
dependent protein tyrosine phosphorylation. 
Ac~no~iedge~ents: Supported by National Institutes of Health grant 
ES03425. The authors thank Dr. Joseph Schlessinger for helpful com- 
ments concerning this manuscript. 
References 
[l] Schlessinger, .I. and Ullrich, A. (1992) Neuron 9, 383-391 
[2] Shoyab, M., De Larco, J.E. and Todaro, G.J. (1979) Nature 279, 
387-391 
10 M. Errasja, A. SternlFEBS Letters 339 (1994) 7--IV 
[3] Brown, K.D., Dicker, P. and Rozengurt, E. (1979) Biochem. Bio- 
phys. Res. Commun. 86, 1037-1043 
[4] Friedman, B., Fracklton, A.R., Ross, A.H., Connors, J.M., Fujiki, 
H., Sugimura, T. and Rosner, M.R. (1984) Proc. Natl. Acad. Sci. 
USA. 81, 30343038 
[5] Honegger, A.M., Dull, T.J., Felder, S., Van Obberghen, E., Bellot, 
F., Szapary, D., Schmidt, A., Ullrich, A. and Schlessinger, J. 
(1987) Cell 51, 199-209 
[6] Hunter, T., Ling, N. and Cooper, J.A. (1984) Nature 311,480-483 
[7] Cachet, C., Gill, G.N., Meisenhelder, J., Cooper, J.A.. and 
Hunter, T. (1984) J. Biol. Chem. 259, 2553-2558 
[8] Downward, J., Watertield, M.D. and Parker, P. (1985) J. Biol. 
Chem. 260, 14538-14546 
[9] Lin, C.R., Chen, W., Lazar, C.S., Carpenter, C.D., Gill, G.N., 
Evans, R.M. and Rosenfeld, M.G. (1986) Cell 44, 839-848 
[lo] Davis, R.J. (1988) J. Biol. Chem. 263, 9462-9469 
[1 1] Livneh, E.. Dull, T.J., Berent, E., Prywes, R., Ullrich, A. and 
Schlessinger, J. (1988) Mol. Cell. Biol. 8, 2302-2308 
[12] Takishima, K., Griswold-Prenner, I., Ingebristen, T. and Rosner, 
M.R. (1991) Proc. Natl. Acad. Sci. USA. 88, 2520-2524 
[13] Northwood, I.C., Gonzales, F.A., Wartman, M. and Davis, R.J. 
(1991) J. Biol. Chem. 266, 15266-15276 
[14] Fisher, E.H.. Charbonneau, H. and Tanks. N.K. (1991) Science 
253, 401406 
[15] Brautigan, D.L. and Pinaut, F.M. (1991) Proc. Natl. Acad. Sci. 
USA 88, 6696-6700 
[16] Garcia-Morales, P., Minami, Y., Luong, E., Klausner, R.D., and 
Samelson, L.E. (1990) Proc. Natl. Acad. Sci. USA. 87,9255-9259 
[17] Mooney, R.A., Freund, G.G., Way, B.A. and Bordwell, K.L. 
(1992) J. Biol. Chem. 267, 23443-23446 
[I 81 Faure, R., Baquiran, G., Bergeron, J.J.M. and Posner, B.I. (1992) 
J. Biol. Chem. 267, 11215-11221 
[19] Griswold-Prenner, I., Carlins, CR. and Rosner, M.R. (1993) J. 
Biol. Chem. 268, 13050-13054 
[20] Bradford, M.M. (176) Anal. Biochem. 72, 248-254 
(211 Margolis, B., Rhee. S.G., Felder, S., Mervic, M., Lyall, R., 
Levitski, A., Ullrich, A., Zilberstein, A. and Schlessinger, J. (1989) 
Cell 57. 1101-l 107 
[22] Lax, I., Bellot, F., Howk, R., Ullrich, A., Givol, D. and Schlessin- 
ger, J. (1989) EMBO J. 8, 421427 
[23] Rossomando, A.R., Payne, D.M., Weber, M.J. and Sturgill, T.W. 
(1989) Proc. Natl. Acad. Sci. USA 86, 694(X6943 
[24] Chao, T.S.O., Byron, K.L., Lee, K.M., Villereal, M. and Rosner, 
M.R. (1992) J. Biol. Chem. 267, 1987619883 
